The food and drug ministry of South Korea has said that the country has approved US pharmaceutical company Pfizer Inc's (NYSE:PFE) COVID-19 vaccine for use with children aged five to 11 years, Reuters news agency reported on Wednesday.
In a statement, the ministry said that children should get one-third of the regular dose, twice with a three week interval.
Children with significantly declined immunity can get a booster four weeks later, the statement added.
GSK secures EU approval for fully liquid Menveo vaccine
Scancell reports promising SCOPE trial data for SCIB1 in advanced melanoma
Transgene teams up with ProBioGen for individualised cancer vaccines
Bio-Works Technologies AB secures LOI for vaccine manufacturing product
LakeShore Biopharma's Phase III YSJA Rabies Vaccine clinical trial receives Chinese NMPA approval
Merck's CAPVAXIVE shows promising immune responses in adults at risk of pneumococcal disease
GSK PLC announces acceptance of NDA for gepotidacin by US FDA